{"id":"https://openalex.org/W2587080119","doi":"https://doi.org/10.1182/blood.v126.23.3759.3759","title":"Evaluation of Patient-Derived Xenografts for Modeling Outcome of Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia","display_name":"Evaluation of Patient-Derived Xenografts for Modeling Outcome of Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2587080119","doi":"https://doi.org/10.1182/blood.v126.23.3759.3759","mag":"2587080119"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.3759.3759","doi":"https://doi.org/10.1182/blood.v126.23.3759.3759","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.3759.3759","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048781138","display_name":"Abdulmohsen M. Alruwetei","orcid":"https://orcid.org/0000-0001-8472-0440","observed_orcids":["https://orcid.org/0000-0001-8472-0440"]},"institutions":[{"id":"https://openalex.org/I156216236","display_name":"Qassim University","ror":"https://ror.org/01wsfe280","country_code":"SA","type":"education","lineage":["https://openalex.org/I156216236"]},{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU","SA"],"is_corresponding":true,"raw_author_name":"Abdulmohsen M Alruwetei","raw_affiliation_strings":["Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia","College of Applied Medical Science, Medical laboratory, Qassim University, Qassim, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia","institution_ids":["https://openalex.org/I31746571"]},{"raw_affiliation_string":"College of Applied Medical Science, Medical laboratory, Qassim University, Qassim, Saudi Arabia","institution_ids":["https://openalex.org/I156216236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110170888","display_name":"Hern\u00e1n Carol","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Hernan Carol","raw_affiliation_strings":["Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076557705","display_name":"Rosemary Sutton","orcid":"https://orcid.org/0000-0002-0188-6005","observed_orcids":["https://orcid.org/0000-0002-0188-6005"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Rosemary Sutton","raw_affiliation_strings":["Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078090612","display_name":"Glenn M. Marshall","orcid":"https://orcid.org/0000-0002-2503-0762","observed_orcids":["https://orcid.org/0000-0002-2503-0762"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4210125633","display_name":"Sydney Children's Hospital","ror":"https://ror.org/02tj04e91","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210125633","https://openalex.org/I4210149013"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Glenn M Marshall","raw_affiliation_strings":["Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia","Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia","institution_ids":["https://openalex.org/I31746571"]},{"raw_affiliation_string":"Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia","institution_ids":["https://openalex.org/I4210125633"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028049853","display_name":"Richard B. Lock","orcid":"https://orcid.org/0000-0002-3436-9071","observed_orcids":["https://orcid.org/0000-0002-3436-9071"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Richard B Lock","raw_affiliation_strings":["Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia","institution_ids":["https://openalex.org/I31746571"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5048781138","https://openalex.org/A5076557705","https://openalex.org/A5110170888"],"corresponding_institution_ids":["https://openalex.org/I156216236","https://openalex.org/I31746571"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.33836689,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"126","issue":"23","first_page":"3759","last_page":"3759"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pediatric-b-cell-precursor-acute-lymphoblastic-leukemia","display_name":"pediatric B-cell precursor acute lymphoblastic leukemia","score":0.8619999885559082},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.984000027179718},{"id":"https://openalex.org/keywords/recurrence-prediction","display_name":"recurrence prediction","score":0.8759999871253967},{"id":"https://openalex.org/keywords/leukemia-engraftment","display_name":"leukemia engraftment","score":0.7789999842643738},{"id":"https://openalex.org/keywords/nsg-mice","display_name":"NSG mice","score":0.7319999933242798},{"id":"https://openalex.org/keywords/nod-scid-mice","display_name":"NOD/SCID mice","score":0.9710000157356262},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.6949999928474426},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9929999709129333},{"id":"https://openalex.org/keywords/l-asparaginase","display_name":"L-asparaginase","score":0.9850000143051147},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8529999852180481},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.652999997138977},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6359999775886536},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.5360000133514404}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7450726628303528},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.6397644281387329},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5283311605453491},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5282824635505676},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.518937349319458},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5145961046218872},{"id":"https://openalex.org/C2781107101","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Acute lymphocytic leukemia","level":4,"score":0.5022778511047363},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.4923971891403198},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4896548390388489},{"id":"https://openalex.org/C2776611710","wikidata":"https://www.wikidata.org/wiki/Q16888295","display_name":"Induction chemotherapy","level":3,"score":0.4723309874534607},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4635782241821289},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.374083936214447},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35354721546173096},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.2948915362358093},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.25711843371391296}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.3759.3759","doi":"https://doi.org/10.1182/blood.v126.23.3759.3759","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.3759.3759","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6927244155","https://openalex.org/W3034191415","https://openalex.org/W4235501165","https://openalex.org/W3096713005","https://openalex.org/W4287832071","https://openalex.org/W4415290387","https://openalex.org/W6945900299","https://openalex.org/W2111008003","https://openalex.org/W2746093273","https://openalex.org/W2885867646"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Children":[2],"with":[3,40,234,319,362,370,375,390,437,469,524,575],"acute":[4],"lymphoblastic":[5],"leukemia":[6],"(ALL)":[7],"are":[8,32,85],"stratified":[9,33],"at":[10,208],"diagnosis":[11,209],"based":[12,166,251],"on":[13,167,252],"molecular/cytogenetic":[14],"characteristics":[15],"and":[16,38,150,169,187,228,243,265,288,306,344,433,446,506,510,532,543,588],"their":[17],"response":[18,73,141],"to":[19,22,70,77,87,114,138,142,146,269,274,280,301,315,357,400,464,563,566,584,612],"initial":[20],"treatment":[21,231,323,481],"receive":[23],"risk-adapted":[24],"multi-agent":[25],"chemotherapy.":[26],"The":[27,61,79,121,277,327,545],"majority":[28],"of":[29,43,57,63,74,82,104,123,133,152,159,212,223,232,240,255,321,329,387,408,431,482,489,501,548,573,579,592,610],"ALL":[30,97,119,136,162,346],"patients":[31,59,76,83,163,410,422,444,461],"as":[34],"Intermediate":[35],"Risk":[36],"(IR)":[37],"present":[39],"moderate":[41],"levels":[42],"minimal":[44],"residual":[45],"disease":[46],"(MRD<5x104)":[47],"after":[48],"receiving":[49],"induction":[50,237,402],"therapy,":[51],"although":[52],"an":[53,112,483,576],"unacceptably":[54],"high":[55],"proportion":[56,254],"these":[58],"relapse.":[60],"lack":[62],"specific":[64],"prognostic":[65],"features":[66],"makes":[67],"it":[68],"difficult":[69],"predict":[71,139],"the":[72,102,130,148,182,253,262,266,286,383,405,409,419,441,455,459,473,477],"IR":[75,96,134,160,596],"treatment.":[78],"early":[80,180,230],"identification":[81],"who":[84],"destined":[86],"relapse":[88,116,586],"would":[89],"facilitate":[90],"improvements":[91],"in":[92,101,108,118,194,261,324,352,424,478,487,512,520,557,595],"tailored":[93],"treatments":[94],"for":[95,297,333],"patients.":[98,120],"Recent":[99],"progress":[100],"development":[103,149],"patient-derived":[105],"xenografts":[106],"(PDXs)":[107],"immune-deficient":[109],"mice":[110,233,294,335,337,341,354,364],"represents":[111],"opportunity":[113],"improve":[115,382],"prediction":[117,587],"aims":[122],"this":[124],"study":[125],"were":[126,164,192,271,295,312,414,517],"to:":[127],"(1)":[128,215],"optimize":[129],"engraftment":[131,247,270,330,388],"conditions":[132],"pediatric":[135,161,597],"samples":[137],"patient":[140,175,275],"treatment;":[143],"and,":[144],"(2)":[145,221],"assess":[147],"mechanisms":[151,591],"therapy-induced":[153],"drug":[154,426,593],"resistance.":[155,494],"Methods:":[156],"Two":[157],"pairs":[158],"matched":[165],"clinical":[168,376,395,406],"genetic":[170],"features,":[171],"except":[172],"that":[173,454,491,516,550,555],"one":[174,199],"from":[176,293,411,418,440,458,472],"each":[177],"pair":[178],"relapsed":[179],"while":[181],"other":[183],"remains":[184],"relapse-free":[185],"(ALL-Rel":[186],"ALL-CR1,":[188],"respectively).":[189],"Three":[190],"parameters":[191],"varied":[193],"establishing":[195],"PDXs":[196,291,456,523,574],"by":[197],"inoculating":[198],"million":[200],"bone":[201],"marrow":[202],"(BM)":[203],"derived":[204,417,439,457,471],"biopsy":[205],"cells":[206,260,347,490],"collected":[207],"into":[210],"groups":[211],"4":[213],"mice:":[214],"mouse":[216,258],"strain":[217],"(NOD/SCID":[218],"vs.":[219,226],"NSG);":[220],"site":[222],"inoculation":[224,379],"(intravenous":[225],"intra-femoral);":[227],"(3)":[229],"a":[235,525],"2-week":[236],"chemotherapy":[238,403],"regimen":[239,578],"vincristine,":[241,304],"dexamethasone,":[242],"L-asparaginase":[244,467],"(VXL).":[245],"Leukemia":[246],"was":[248,282,331],"monitored":[249],"weekly":[250],"human":[256],"versus":[257,339],"CD45+":[259],"murine":[263],"PB,":[264],"median":[267,278],"times":[268],"compared":[272,284,296,314,361,389,436,468],"according":[273],"outcome.":[276,377,396],"time":[279,356],"engraft":[281,358],"also":[283,313,348],"between":[285],"VXL-treated":[287],"non-treated":[289],"groups.":[290],"harvested":[292],"ex":[298,450],"vivo":[299,425,451,479,571],"sensitivity":[300,565],"single":[302],"agent":[303],"dexamethasone":[305],"L-asparaginase.":[307],"PDX":[308,398,485],"gene":[309],"expression":[310,496,547],"profiles":[311],"identify":[316,589],"pathways":[317],"associated":[318,374,503],"evasion":[320],"VXL":[322,401,480],"vivo.":[325],"Results:":[326],"efficiency":[328,384],"greater":[332],"NSG":[334,353],"(29/32":[336],"engrafted)":[338],"NOD/SCID":[340,363],"(20/32":[342],"mice),":[343],"primary":[345],"engrafted":[349],"significantly":[350,518],"faster":[351],"(median":[355],"71.1":[359],"days)":[360,366,435],"(83.5":[365],"(P":[367],"<":[368,530,535],"0.01),":[369],"no":[371],"apparent":[372],"difference":[373],"Intrafemoral":[378],"did":[380],"not":[381],"or":[385,466],"speed":[386],"intravenous":[391],"inoculation,":[392],"nor":[393],"predicted":[394],"However,":[397],"responses":[399],"reflected":[404],"outcome":[407],"whom":[412],"they":[413],"derived;":[415],"those":[416,438,470],"2":[420,442],"ALL-Rel":[421,460],"exhibited":[423,462,492],"resistance":[427,463,594],"(leukemia":[428],"growth":[429],"delay":[430],"1":[432],"6.2":[434],"ALL-CR1":[443,474,484],"(34.7":[445],">119.8":[447],"days).":[448],"Further,":[449],"analysis":[452],"showed":[453],"vincristine":[465,493,521],"cases.":[475],"Moreover,":[476],"resulted":[486],"selection":[488,572],"Gene":[495],"profiling":[497],"revealed":[498],"significant":[499],"up-regulation":[500],"microtubule":[502,552,558],"proteins":[504],"(MAPs)":[505],"tubulin":[507],"isotypes":[508],"(alpha":[509],"beta)":[511],"vincristine-resistant":[513],"PDXs.":[514],"Genes":[515],"upregulted":[519],"resistant":[522],"false":[526],"discovery":[527],"rate":[528],"(FDR)":[529],"0.05":[531],"P":[533],"value":[534],"0.02":[536],"include":[537],"TUBB6,":[538],"TUBA1A,":[539],"TUBA1B,":[540],"MAP1S,":[541],"TUBA3D":[542],"TBCA.":[544],"increased":[546],"genes":[549],"affect":[551],"functions":[553],"suggest":[554],"changes":[556],"dynamics":[559],"and/or":[560],"stability":[561],"led":[562],"decreased":[564],"antimicrotubule":[567],"agents.":[568],"Conclusions:":[569],"In":[570],"induction-type":[577],"chemotherapeutic":[580],"drugs":[581],"may":[582],"lead":[583],"improved":[585],"novel":[590],"ALL.":[598],"Support:":[599],"Steven":[600],"Walter":[601],"Foundation;":[602],"NHMRC":[603],"Australia,":[604],"APP1057746":[605],"Disclosures":[606],"No":[607],"relevant":[608],"conflicts":[609],"interest":[611],"declare.":[613]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-02-17T00:00:00"}